.png){kind=logo}
GC Asia
Pfizer underscores insatiable demand theory
In what is becoming a familiar theme, US drug company Pfizer this week issued an acquisition related high grade bond that swiftly dropped to much lower yields after pricing.
It was priced only four weeks after Roche, another pharmaceutical, brought $16.5bn in the biggest US dollar bond offering yet.
This ...Already a subscriber? Login
-
Latest news from Corporate Bonds
-
T-Mobile calls for yet more bond cash
22 Oct 2020 -
A2A breaks long end yield record for Italian corporates, Blackstone prices
22 Oct 2020 -
Two EM deals pulled in a week, but last chance market open, say investors
22 Oct 2020 -
Upstart broker spurs Schuldschein trading
22 Oct 2020 -
IG secondaries spur records but fears grow about reckoning
22 Oct 2020
-
-
Latest news from Corporate Bonds
-
T-Mobile calls for yet more bond cash
22 Oct 2020 -
A2A breaks long end yield record for Italian corporates, Blackstone prices
22 Oct 2020 -
Two EM deals pulled in a week, but last chance market open, say investors
22 Oct 2020 -
Upstart broker spurs Schuldschein trading
22 Oct 2020 -
IG secondaries spur records but fears grow about reckoning
22 Oct 2020
-
